Larimar Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $41,758,000.
Profit Margin
| 2014 | 0 | -36.57M | |
|---|---|---|---|
| 2015 | 0 | -74.28M | |
| 2016 | 0 | -57.87M | |
| 2017 | 0 | -52.02M | |
| 2018 | 0 | -61.36M | |
| 2019 | 0 | -23.13M | |
| 2020 | 0 | -42.32M | |
| 2021 | 0 | -50.31M | |
| 2022 | 0 | -34.18M | |
| 2023 | 0 | -36.94M |
LRMR Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 311K | 272K | 326K | 155K | 78K | 261K | 188K | 212K | 70K | 0 |
Gross profit | -311K | -272K | -326K | -155K | -78K | -261K | -188K | -212K | -70K | 0 |
Operating exp. | ||||||||||
Research and development | 27.35M | 24.25M | 38.39M | 31.40M | 20.79M | 49.52M | 41.73M | 39.77M | 54.61M | 27.39M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 12.93M | -212K | -1.15M | -70K | 0 |
Total operating expenses | 41.75M | 36.52M | 50.46M | 42.80M | 23.21M | 62.46M | 53.68M | 56.91M | 73.74M | 35.53M |
Operating income | -41.75M | -36.52M | -50.46M | -42.80M | -23.21M | -62.72M | -53.87M | -57.12M | -73.81M | -35.53M |
Other income (expenses), net | 4.80M | 1.17M | -171K | 322K | 82K | -246K | 947K | -1.05M | -473K | -1.03M |
Income before tax | -36.94M | -35.35M | -50.63M | -42.48M | -23.13M | -62.96M | -52.92M | -58.17M | -74.28M | -36.57M |
Income tax expense | 0 | -1.17M | -326K | -155K | 0 | -1.6M | -900K | -300K | -946K | 0 |
Net income | -36.94M | -34.18M | -50.31M | -42.32M | -23.13M | -61.36M | -52.02M | -57.87M | -74.28M | -36.57M |
Earnings per share | ||||||||||
Basic EPS | -0.84 | -1.33 | -2.93 | -3.56 | -7.43 | -22.85 | -22.76 | -25.44 | -33.32 | -15.14 |
Diluted EPS | -0.84 | -1.33 | -2.93 | -3.56 | -7.43 | -22.85 | -22.76 | -25.44 | -33.32 | -15.14 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |